EUVIMEDEUVIMED entdecken
Open Access

ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma

Xiaofei Wang, Lin Yao, Zheng Li, Jiaen Zhang, Mingjian Ruan, Yelin Mulati, Ying Gan, Qian Zhang

International Journal of Biological Sciences · 2024

DOI: 10.7150/ijbs.89785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Xiaofei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; Beijing Key Laboratory of Urogenital Diseases (Male…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAnimalsHumansCell Line, TumorCell ProliferationMammalsMethylationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTranscription FactorsRepressor ProteinsDNA-Binding ProteinsNuclear ProteinsCell Cycle Proteins

Stichwörter der Autor:innen

BANPPI3K/AKT/mTORZNF471methylationrenal cell carcinoma

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTranscription FactorsZNF471 protein, humanRepressor ProteinsBANP protein, humanDNA-Binding ProteinsNuclear ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, National Urological Cancer…
  • Peking University Binhai Hospital, Tianjin 300450, China.

Zitieren

APA

Wang, X., Yao, L., Li, Z., Zhang, J., Ruan, M., Mulati, Y., Gan, Y., & Zhang, Q. (2024). ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.89785

Vancouver

Wang X, Yao L, Li Z, Zhang J, Ruan M, Mulati Y, et al. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma. International Journal of Biological Sciences. 2024. doi:10.7150/ijbs.89785

BibTeX
@article{Wang2024,
  author = {Wang, Xiaofei and Yao, Lin and Li, Zheng and Zhang, Jiaen and Ruan, Mingjian and Mulati, Yelin and Gan, Ying and Zhang, Qian},
  title = {ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  doi = {10.7150/ijbs.89785}
}
Kostenlos starten →